Is it Time to Dump Longeveron Inc (LGVN) Stock After it Has Fallen 5.70% in a Week?

Overall market sentiment has been down on Longeveron Inc (LGVN) stock lately. LGVN receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.

Longeveron Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on LGVN!

See Full LGVN Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With LGVN Stock Today?

Longeveron Inc (LGVN) stock is up 3.51% while the S&P 500 has fallen -0.28% as of 10:44 AM on Thursday, Jan 13. LGVN is up $0.32 from the previous closing price of $9.11 on volume of 217,088 shares. Over the past year the S&P 500 is up 19.77% while LGVN is up 27.26%. LGVN lost -$0.77 per share in the over the last 12 months. To screen for more stocks like Longeveron Inc click here.

More About Longeveron Inc

Longeveron Inc is a biotechnology company developing cellular therapies for specific ageing-related and life-threatening conditions. It is involved in sponsoring clinical trials in the following indications: Aging Frailty, Alzheimer's disease, the Metabolic Syndrome, Acute Respiratory Distress Syndrome (ARDS), and Hypoplastic left heart syndrome (HLHS). Click Here to get the full Stock Report for Longeveron Inc stock.